150 related articles for article (PubMed ID: 9776014)
1. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions.
de Sèze M; Wiart L; Joseph PA; Dosque JP; Mazaux JM; Barat M
Neurourol Urodyn; 1998; 17(5):513-23. PubMed ID: 9776014
[TBL] [Abstract][Full Text] [Related]
2. [Reiterated intravesical instillation of capsaicin in neurogenic detrusor hyperreflexia: a 5-years experience of 100 instillations].
de Sèze M; Wiart L; de Sèze MP; Joseph PA; Brochet B; Ferrière JM; Mazaux JM; Barat M
Ann Readapt Med Phys; 2001 Nov; 44(8):514-24. PubMed ID: 11788114
[TBL] [Abstract][Full Text] [Related]
3. The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results.
Wiart L; Joseph PA; Petit H; Dosque JP; de Sèze M; Brochet B; Deminière C; Ferrière JM; Mazaux JM; N'Guyen P; Barat M
Spinal Cord; 1998 Feb; 36(2):95-9. PubMed ID: 9494998
[TBL] [Abstract][Full Text] [Related]
4. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
de Sèze M; Wiart L; de Sèze MP; Soyeur L; Dosque JP; Blajezewski S; Moore N; Brochet B; Mazaux JM; Barat M; Joseph PA
J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887
[TBL] [Abstract][Full Text] [Related]
5. Intravesical capsaicin for treatment of detrusor hyperreflexia.
Fowler CJ; Beck RO; Gerrard S; Betts CD; Fowler CG
J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):169-73. PubMed ID: 8126498
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia--a double-blind, placebo-controlled clinical trial.
Stöhrer M; Madersbacher H; Richter R; Wehnert J; Dreikorn K
Spinal Cord; 1999 Mar; 37(3):196-200. PubMed ID: 10213329
[TBL] [Abstract][Full Text] [Related]
7. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
[TBL] [Abstract][Full Text] [Related]
8. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial.
Kim JH; Rivas DA; Shenot PJ; Green B; Kennelly M; Erickson JR; O'Leary M; Yoshimura N; Chancellor MB
J Spinal Cord Med; 2003; 26(4):358-63. PubMed ID: 14992337
[TBL] [Abstract][Full Text] [Related]
9. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases.
Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D
Scand J Urol Nephrol; 1998 Sep; 32(5):331-4. PubMed ID: 9825395
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
Abdel-Gawad M; Dion SB; Elhilali MM
J Urol; 2001 May; 165(5):1739-44. PubMed ID: 11342967
[TBL] [Abstract][Full Text] [Related]
11. Intravesical vanilloids and neurogenic incontinence: ten years experience.
Lazzeri M; Spinelli M; Zanollo A; Turini D
Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions.
Kuo HC
BJU Int; 2003 Oct; 92(6):597-601. PubMed ID: 14511042
[TBL] [Abstract][Full Text] [Related]
13. Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial.
Stöhrer M; Bauer P; Giannetti BM; Richter R; Burgdörfer H; Mürtz G
Urol Int; 1991; 47(3):138-43. PubMed ID: 1771701
[TBL] [Abstract][Full Text] [Related]
14. Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study.
Lazzeri M; Calò G; Spinelli M; Guerrini R; Salvadori S; Beneforti P; Sandri S; Regoli D; Turini D
Urology; 2003 May; 61(5):946-50. PubMed ID: 12736013
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravesical botulinum neurotoxin-A injection on detrusor hyperreflexia in spinal cord injured patients.
Ge XT; Li YF; Wang Q; Zhao JN
Drug Res (Stuttg); 2015 Jun; 65(6):327-31. PubMed ID: 25350080
[TBL] [Abstract][Full Text] [Related]
16. Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized study.
de Sèze M; Gallien P; Denys P; Labat JJ; Serment G; Grise P; Salle JY; Blazejewski S; Hazane C; Moore N; Joseph PA
Neurourol Urodyn; 2006; 25(7):752-7. PubMed ID: 16986136
[TBL] [Abstract][Full Text] [Related]
17. Intravesical instillation of capsaicin in urology: A review of the literature.
de Sèze M; Wiart L; Ferrière J; de Sèze MP; Joseph P; Barat M
Eur Urol; 1999 Oct; 36(4):267-77. PubMed ID: 10473984
[TBL] [Abstract][Full Text] [Related]
18. Urodynamic effects of intravesical instillation of atropine and phentolamine in patients with detrusor hyperactivity.
Ekström B; Andersson KE; Mattiasson A
J Urol; 1993 Jan; 149(1):155-8. PubMed ID: 8417203
[TBL] [Abstract][Full Text] [Related]
19. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.
George J; Tharion G; Richar J; Macaden AS; Thomas R; Bhattacharji S
ScientificWorldJournal; 2007 Oct; 7():1683-90. PubMed ID: 17982563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
